Novels of modern domestic legislation in the field of genomic therapy and the prospects for its implementation in everyday life

About the author:

Stanislav A. Vasiliev, Cand. Sci. (Jur.), Associate Professor, Deputy Director for Development and Scientific Work of the Law Institute, Sevastopol State University; mnogoslov@mail.ru; ORCID: 0000-0003-2752-240X

Abstract:

Recent events in Russia and in the world have shown the high importance of medicine for modern society. It became obvious that a large number of threats are concentrated from the point of view of the consistency of the healthcare system, which can be ensured by coordinated actions of state structures based on a high-quality regulatory legal framework. On the other hand, new means and methods of treating various diseases seem to be important. One of these areas of high-tech medicine is the diagnosis and editing of the human genome. There is practically no normative legal regulation of this activity, despite the fact that modern legal science is replete with proposals in this regard and notes an acute shortage of this regulation. Nevertheless, these medical technologies had some influence on minor changes in the legal regulation of this area, including the special powers of the federal territory “Sirius”, revision of the system of state control and supervision over the production and distribution of biomedical cell products and some progress in causing and compensating harm from conducting genomic research. The scientific novelty of this work is the conclusion about the impact of genomic medicine on legal regulation in Russia, as well as proposals for further improvement of such work. The purpose of the study is to analyze the latest legislative innovations to assess the impact of modern medical technologies on them, as well as to determine the main directions for further improving the legal system in this area. Methodology. To carry out this study, we analyzed the domestic legal regulation on the issue of genomic therapy in its dynamics over the past few years, used the method of expert assessments, the comparative legal method. The main suggestions were made by the modeling method. Key conclusions are made based on general philosophical methods of scientific knowledge — analysis and synthesis, deduction and induction.

References:

1. André den Exter. 2019. Speech at the International Symposium “Law and modern technologies in medicine”. Moscow State Law University. [In Russian]
2. Bliznyuk E. A. 2021. Speech at the All-Russian Scientific and Practical Conference dedicated to the problems of urban planning. Legislative Assembly of the city of Sevastopol. [In Russian]
3. Bogdan V. V. 2021. “New medical technologies: Concept efficiency and legal forecast (private law aspect)”. Civil Law, no. 4, pp. 14-16. [In Russian]
4. Business magazine about the healthcare industry “Vademecum”. A genetic laboratory will open in Sirius by 2022. Accessed on 28 September 2021. https://vademec.ru/news/2021/05/17/v-siriuse-k-2022-godu-otkroetsya-geneticheskaya-laboratoriya-/ [In Russian]
5. Precedents of the Grand Chamber of the European Court of Human Rights by member states of the Council of Europe. 2009. Case S. and Marper against the United Kingdom. Complaints No. 30562/04 and No. 30566/04. No. 9. Pp. 496-516. [In Russian]
6. Kazaryan A. A., Tyurina Yu. G. 2021. “Assessment of the adequacy of tools for replenishing lost income and covering the federal budget deficit during the COVID-19 pandemic”. Financial Business, no. 5 (215), pp. 58-60. [In Russian]
7. Kosov M. E., Koshevaya V. E. 2021. “Factors negatively affecting the formation of federal budget revenues during a pandemic”. Bulletin of Economic Security, no. 1, pp. 231-240. [In Russian]
8. Kupryushina O. M., Sherstyukova I. N. 2021. “Analysis of tax revenues to the budget of the Russian Federation during a pandemic”. Actual Problems of Accounting, Economic Analysis and Financial and Economic Control of the Organization. Materials of the 8th International Scientific and Practical Conference. Voronezh: Voronezh State University. Pp. 90-93. [In Russian]
9. Levushkin A. N. 2020. “Legal regulation of genomic technologies, gene diagnostics and gene therapy and the introduction of their results into medical practice”. Bulletin of the University named after O. E. Kutafina (Moscow State Law Academy), no. 5 (69), pp. 42-50. [In Russian]
10. Mokhov A. A., Chaplenko A. A., Yavorsky A. N. 2019. “The use of genomic editing technologies: achievements and prospects”. Biomedicine, vol. 15, no. 2, pp. 34-42. [In Russian]
11. Collected Legislation of the Russian Federation. 2021. No. 27 (Part I). Art. 5159. On amendments to certain legislative acts of the Russian Federation in connection with the adoption of the Federal Law “On Experimental Legal Regimes in the Field of Digital Innovations in the Russian Federation”: Federal Law of 2 July 2021 No. 331-FZ. [In Russian]
12. Collected Legislation of the Russian Federation. 2021. No. 27 (Part I). Art. 5179. On amendments to certain legislative acts of the Russian Federation: Federal Law of 2 July 2021 No. 351-FZ. [In Russian]
13. Collected Legislation of the Russian Federation. 2020. No. 52 (Part I). Art. 8584. On amendments to the Federal Law “On the Basics of Health Protection of Citizens in the Russian Federation”: Federal Law of 22 December 2020 No. 438-FZ. [In Russian]
14. Official site of the educational center “Sirius”. About genomic medicine and admission to Skoltech. Accessed on 28 September 2021. https://sochisirius.ru/news/1086 [In Russian]
15. Perkhov V. I., Lyutsko V. V. 2019. “Macroeconomic expenditures on health care in Russia and abroad”. Modern Problems of Health Care and Medical Statistics, no. 2, pp. 334-345. [In Russian]
16. Collected Legislation of the Russian Federation. 2021. No. 27 (Part III). Art. 5438. Regulations on federal state control (supervision) in the field of circulation of biomedical cell products, approved by the Decree of the Government of the Russian Federation of 30 June 2021 No. 1062. [In Russian]
17. Posulikhina N. S. 2020. “Licensed regime of circulation of biomedical cell products: problems of law enforcement”. Actual Problems of Russian Law, no. 5, pp. 160-167. [In Russian]
18. Suvorov G. N. 2019. Speech at the International Symposium “Law and Modern Technologies in Medicine”. Moscow State Law University. [In Russian]
19. Sedova N. N., Shestakov A. A. 2017. “Ethical parameters of the application of the Federal Law No. 180-FZ ‘On Biomedical Cell Products’”. Medical Law, no. 4, pp. 3-7. [In Russian]
20. Suvorov G. N., Lyutaya E. D., Zenin S. S., Medvedev M. V. 2020. “Estimation of costs and economic efficiency of genetic screening in the framework of prenatal diagnostics in Russia and foreign countries: Factor analysis”. Prenatal Diagnostics, vol. 19, no. 3, pp. 281-288. [In Russian]
21. Tuzhilova-Ordanskaya E. M., Akhtyamova E. V. 2021. “Problems of civil regulation in the field of protecting the rights of a citizen in the Russian Federation when using genetic information”. Bulletin of Perm University. Legal sciences, no. 2, pp. 263-284. [In Russian]
22. Burtsev A. K., Osavelyuk A. M., Sarmanaev S. Kh. et al. (ed.) 2020. Formation of the conceptual foundations of the mechanism of legal regulation of genome diagnostics and genomic editing: monograph. Moscow: Jurist. 250 p. [In Russian]
23. Khusainova R. I., Akhtyamova E. V., Minniakhmetov I. R., Sultanova R. I. 2020. “Modern molecular genetic technologies in medicine: Ethical and legal issues”. Legal State: Theory and Practice, no. 2 (60), pp. 123-133. [In Russian]
24. Shilyuk T. O. 2020. “Principles of state regulation in the field of genetic engineering”. Actual Problems of Russian Law, no. 7, pp. 30-38. [In Russian]
25. Case of A.K. v. Latvia. Application No. 33011/08. Strasbourg, 2014. 29 p.
26. Case of Costa and Pavan v. Italy. Application No. 54270/10. Strasbourg, 2012. 13 pp.
27. Case of Evans v. the United Kingdom. Application No. 6339/05. Strasbourg, 2006. 30 pp.
28. Case of Parrillo v. Italy. Application No. 46470/11. Strasbourg, 2015. 92 p.
29. Eichinger J., Elger B. S., Koné I. 2021. “The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review”. BMC Pediatrics, no. 21 (1), p. 387.
30. Erdmann A., Rehmann-Sutter C., Bozzaro C. 2021. “Patients ‘and professionals’ views related to ethical issues in precision medicine: a mixed research syntheses”. BMC Medical Ethics, no. 22 (1), p. 116.
31. Feeney O., Rakić V. 2021. “Genome editing and ‘disenhancement’: Considerations on issues of non-identity and genetic pluralism”. Humanities and Social Sciences Communications, no. 8 (1), p. 116.
32. Figueiredo G. S., de Havilland J. R., Lako M., Figueiredo F. C. 2016. “Cell therapy in practice”. Bioprocessing for Cell Based Therapies, pp. 211-236.
33. Gadwal A., Roy D., Khokhar M. 2021. “CRISPR/Cas-new molecular scissors in diagnostics and therapeutics of COVID-19”. Indian Journal of Clinical Biochemistry, no. 36 (4), pp. 459-467.
34. Hills A., Awigena-Cook J., Genenz K. 2020. “An assessment of the hospital exemption landscape across European Member States: Regulatory frameworks, use and impact”. Cytotherapy, no. 22 (12), pp. 772-779.
35. Knight A., Miller J. 2021. “Prenatal genetic screening, epistemic justice, and reproductive autonomy”. Hypatia, no. 36 (1), pp. 1-21.
36. Mebarki M., Abadie C., Larghero J., Cras A. 2021. “Human umbilical cord-derived mesenchymal stem/stromal cells: A promising candidate for the development of advanced therapy medicinal products”. Stem Cell Research and Therapy, no. 12 (1), p. 152.
37. Renner M., Anliker B., Flory E. 2016. “Regulation for gene and cell therapy medicinal products in Europe”. Gene Therapy and Cell Therapy Through the Liver: Current Aspects and Future Prospects, pp. 105-123.
38. Shum B. O. V., Bennett G., Navilebasappa A., Kumar R. K. 2021. “Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: A case report”. BMC Pediatrics, no. 21 (1), p. 154.
39. Wong J. Z. Y., Chai J. H., Yeoh Y. S. 2021. “Cost effectiveness analysis of a polygenic risk tailored breast cancer screening program in Singapore”. BMC Health Services Research, no. 21 (1), p. 379.